Your browser doesn't support javascript.
loading
Psychometric properties and predictive validity of the PP-ACT.
Shepperd, James A; Webster, Gregory D; Pogge, Gabrielle C; Fedele, David; Prabhakaran, Sreekala; Hunleth, Jean; Waters, Erika A.
Afiliação
  • Shepperd JA; Department of Psychology, University of Florida, Gainesville, FL, USA.
  • Webster GD; Department of Psychology, University of Florida, Gainesville, FL, USA.
  • Pogge GC; Department of Psychology, University of Florida, Gainesville, FL, USA.
  • Fedele D; Department of Clinical & Health Psychology, University of Florida College of Public Health and Health Professions, Gainesville, FL, USA.
  • Prabhakaran S; Department of Clinical & Health Psychology, University of Florida College of Public Health and Health Professions, Gainesville, FL, USA.
  • Hunleth J; Department of Psychology, University of Florida, Gainesville, FL, USA.
  • Waters EA; Department of Surgery, Washington University in Saint Louis School of Medicine, St. Louis, MO, USA.
J Asthma ; 60(1): 174-184, 2023 01.
Article em En | MEDLINE | ID: mdl-35094619
OBJECTIVE: The Parent Proxy Asthma Control Test (PP-ACT) is a self-report measure of asthma control completed by caregivers on behalf of a child. We examined the psychometric properties and the reliability and predictive validity of the PP-ACT. METHODS: We conducted two studies (one cross-sectional, one longitudinal over three months) that surveyed caregivers (N = 1622) of children with asthma. Caregivers completed the PP-ACT and a variety of other measures, including child health outcomes. RESULTS: We found clear evidence that the five-item PP-ACT assesses two distinct constructs: Items 1-4 (which we call the PP-ACT4) assess symptoms, impairment, and use of a short acting beta-2 blocker (albuterol); Item 5 assesses caregivers' global subjective assessment of their child's asthma control. In addition, the two constructs function as unique predictors of asthma outcomes. Both the PP-ACT4 and Item 5 predicted unique variance in ED visits, the number of symptom-free days, and child quality of life. Only the PP-ACT4 predicted frequency of ICS use and only at Time 1 in Study 1. Conversely, Item 5 predicted exacerbation frequency whereas the PP-ACT4 did not. CONCLUSION: Our findings suggest that researchers and clinicians should treat the PP-ACT4 and Item 5 as distinct indicators of asthma control because they differentially predict asthma outcomes and likely have distinct meanings to caregivers.Supplemental data for this article is available online at https://doi.org/10.1080/02770903.2022.2036755 .
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Asma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Asma Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article